These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

470 related articles for article (PubMed ID: 19852565)

  • 1. The p38 MAPK inhibitors for the treatment of inflammatory diseases and cancer.
    Yong HY; Koh MS; Moon A
    Expert Opin Investig Drugs; 2009 Dec; 18(12):1893-905. PubMed ID: 19852565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p38 MAP kinases: key signalling molecules as therapeutic targets for inflammatory diseases.
    Kumar S; Boehm J; Lee JC
    Nat Rev Drug Discov; 2003 Sep; 2(9):717-26. PubMed ID: 12951578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sensitization of apoptotically-resistant breast carcinoma cells to TNF and TRAIL by inhibition of p38 mitogen-activated protein kinase signaling.
    Weldon CB; Parker AP; Patten D; Elliott S; Tang Y; Frigo DE; Dugan CM; Coakley EL; Butler NN; Clayton JL; Alam J; Curiel TJ; Beckman BS; Jaffe BM; Burow ME
    Int J Oncol; 2004 Jun; 24(6):1473-80. PubMed ID: 15138590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of p38 MAPK is a key step in tumor necrosis factor-mediated inflammatory bone destruction.
    Zwerina J; Hayer S; Redlich K; Bobacz K; Kollias G; Smolen JS; Schett G
    Arthritis Rheum; 2006 Feb; 54(2):463-72. PubMed ID: 16447221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Indomethacin induces apoptosis in 786-O renal cell carcinoma cells by activating mitogen-activated protein kinases and AKT.
    Ou YC; Yang CR; Cheng CL; Raung SL; Hung YY; Chen CJ
    Eur J Pharmacol; 2007 Jun; 563(1-3):49-60. PubMed ID: 17341418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MAPK signal transduction underlying brain inflammation and gliosis as therapeutic target.
    Kaminska B; Gozdz A; Zawadzka M; Ellert-Miklaszewska A; Lipko M
    Anat Rec (Hoboken); 2009 Dec; 292(12):1902-13. PubMed ID: 19943344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The p38 MAP kinase pathway as a therapeutic target in inflammatory disease.
    Saklatvala J
    Curr Opin Pharmacol; 2004 Aug; 4(4):372-7. PubMed ID: 15251131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel strategies for inhibition of the p38 MAPK pathway.
    Zhang J; Shen B; Lin A
    Trends Pharmacol Sci; 2007 Jun; 28(6):286-95. PubMed ID: 17482683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitogen-activated protein kinase (MAPK) blockade of bovine preimplantation embryogenesis requires inhibition of both p38 and extracellular signal-regulated kinase (ERK) pathways.
    Madan P; Calder MD; Watson AJ
    Reproduction; 2005 Jul; 130(1):41-51. PubMed ID: 15985630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and implementation of three mitogen-activated protein kinase (MAPK) signaling pathway imaging assays to provide MAPK module selectivity profiling for kinase inhibitors: MK2-EGFP translocation, c-Jun, and ERK activation.
    Nickischer D; Laethem C; Trask OJ; Williams RG; Kandasamy R; Johnston PA; Johnston PA
    Methods Enzymol; 2006; 414():389-418. PubMed ID: 17110204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of p38 MAP kinase in lipopolysaccharide-induced production of pro- and anti-inflammatory cytokines and prostaglandin E(2) in human choriodecidua.
    Shoji T; Yoshida S; Mitsunari M; Miyake N; Tsukihara S; Iwabe T; Harada T; Terakawa N
    J Reprod Immunol; 2007 Oct; 75(2):82-90. PubMed ID: 17617469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Challenges of developing therapeutics that target signal transduction in patients with gynecologic and other malignancies.
    Rowinsky EK
    J Clin Oncol; 2003 May; 21(10 Suppl):175s-186s. PubMed ID: 12743132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TNF-alpha promotes a stop signal that inhibits neutrophil polarization and migration via a p38 MAPK pathway.
    Lokuta MA; Huttenlocher A
    J Leukoc Biol; 2005 Jul; 78(1):210-9. PubMed ID: 15845648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p38 MAP kinase: a convergence point in cancer therapy.
    Olson JM; Hallahan AR
    Trends Mol Med; 2004 Mar; 10(3):125-9. PubMed ID: 15102355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of inositol 1,4,5-triphosphate and p38 mitogen-activated protein kinase in reactive oxygen species generation by granulocytes in a cyclic AMP-dependent manner: an age-related phenomenon.
    Chaves MM; Costa DC; Pereira CC; Andrade TR; Horta BC; Nogueira-Machado JA
    Gerontology; 2007; 53(4):228-33. PubMed ID: 17374957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Helicobacter pylori and mitogen-activated protein kinases regulate the cell cycle, proliferation and apoptosis in gastric epithelial cells.
    Ding SZ; Smith MF; Goldberg JB
    J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 2):e67-78. PubMed ID: 18702686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances in targeting the Ras/Raf/MEK/Erk mitogen-activated protein kinase cascade with MEK inhibitors for cancer therapy.
    Friday BB; Adjei AA
    Clin Cancer Res; 2008 Jan; 14(2):342-6. PubMed ID: 18223206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dipyridamole activation of mitogen-activated protein kinase phosphatase-1 mediates inhibition of lipopolysaccharide-induced cyclooxygenase-2 expression in RAW 264.7 cells.
    Chen TH; Kao YC; Chen BC; Chen CH; Chan P; Lee HM
    Eur J Pharmacol; 2006 Jul; 541(3):138-46. PubMed ID: 16765938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential of p38-MAPK inhibitors in the treatment of ischaemic heart disease.
    Clark JE; Sarafraz N; Marber MS
    Pharmacol Ther; 2007 Nov; 116(2):192-206. PubMed ID: 17765316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of the p38 mitogen-activated protein kinase pathway in the generation of arsenic trioxide-dependent cellular responses.
    Giafis N; Katsoulidis E; Sassano A; Tallman MS; Higgins LS; Nebreda AR; Davis RJ; Platanias LC
    Cancer Res; 2006 Jul; 66(13):6763-71. PubMed ID: 16818652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.